Association of polymorphic variants rs6684209 and rs7521023 of the calsequestrin gene (CASQ2) with contractile myocardial function in patients with coronary artery disease
https://doi.org/10.15829/1560-4071-2019-10-16-21
Abstract
Aim. To study the association between polymorphic rs6684209 and rs7521023 variants of the CASQ2 gene and myocardial contractile function and risk factors for the development of chronic heart failure (CHF).
Material and methods. The study included 172 patients with CHF developing on the background of coronary artery disease. We identified polymorphic variants rs6684209 and rs7521023 of the CASQ2 gene by real-time polymerase chain reaction.
Results. There was no association of the rs6684209 variant with CHF and the frequency of cardiac arrhythmias. It was revealed that the carriage of the GG genotype of rs7521023 variant is associated with a higher frequency of dilatation of the left atrium (p=0,044) and an increased end-systolic volume (p=0,045).
Conclusion. Among patients with coronary artery disease, there was no correlation between the rs7521023 and rs6684209 variants of the calsequestrin gene (CASQ2) with the frequency of cardiac arrhythmias. There was no association of the rs6684209 variant with CHF risk factors and parameters of myocardial contractile function. A relationship was found between the GG genotype of the rs7521023 variant and a higher frequency of left atrium dilatation. Among patients taking beta-blockers, the GG genotype is associated with an increase in end-systolic volume.
About the Authors
E. F. MuslimovaRussian Federation
Competing Interests: not
T. Yu. Rebrova
Russian Federation
Competing Interests: not
E. A. Archakov
Russian Federation
Competing Interests: not
D. S. Kondratieva
Russian Federation
Competing Interests: not
Yu. G. Lugacheva
Russian Federation
Competing Interests: not
R. E. Batalov
Russian Federation
Competing Interests:
Research Institute of Cardiology, Tomsk National Research Medical Center
S. A. Afanasiev
Russian Federation
Competing Interests: not
References
1. Mareev VY, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8-158. (In Russ.). doi:10.18087/cardio.2475.
2. Lehnart SE, Maier LS, Hasenfuss G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev. 2009;14:213-24. doi:101007/s10741-009-9146-x.
3. Rebrova TY, Muslimova EF, Kondratieva DS, et al. The role of Ca2+-ATPase 2A (ATP2A2), ryanodine receptors (RYR2), and calsequestrin (CASQ2) gene polymorphisms in the development of heart failure. Russian Journal of Genetics. 2018;54(6):604-8. doi:10.1134/S102279541806008X.
4. Glukhov AV, Kalyanasundaram A, Lou Q, et al. Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within themouse atrial pacemaker complex. European Heart Journal. 2015;36:686-97. doi:10.1093/eurheartj/eht452.
5. Estrada-AvileAs R, RodroAguez G, Zarain-Herzberg A. The cardiac calsequestrin gene transcription is modulated at the promoter by NFAT and MEF-2 transcription factors. PLoS. 2017;12(9):e0184724. doi:10.1371/journal.pone.0184724.
6. Terentyev D, Nori A, Santoro M, et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ. Res. 2006;98;1151-8. doi:10.1161/01.RES.0000220647.93982.08.
7. Refaat MM, Aouizerat BE, Pullinger CR, et al. Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease. Heart Rhythm. 2014;11(4):646-52. doi:10.1016/j.hrthm.2014.01.015.
8. Faggioni M, Knollmann BC. Calsequestrin 2 and arrhythmias. The American Journal of Physiology-Heart and Circulatory Physiology. 2012;302(6):H1250-H1260. doi:10.1152/ajpheart.00779.2011.
9. Arakelyan MS, Poteshkina NG, Mogutova PA. Modifiable and non-modifiable risk factors in predicting the recurrence of atrial fibrillation in patients with arterial hypertension. Russian Journal of Cardiology. 2012;(6):34-8. (In Russ.). doi:1015829/1560-4071-2012-6-34-38.
10. Lednev PV, Belov YV, Komarov RN, et al. Sinus rhythm restoration after left atrial reduction. Khirurgiia (Mosk). 2017;(2):80-2. (In Russ.) doi:10.17116/hirurgia2017280-82.
11. Achkasov EE, Mashkovskii EV, Bogova OT, et al. Morphological and functional features of circulatory system in retired and active elite athletes. Annals of the Russian academy of medical sciences. 2014;69(5-6):34-9. (In Russ.) doi:10.15690/vramn. v69i5-6.1041.
12. Ensembl. rs7521023. http://Jan2019.archive.ensembl.org/Homo_sapiens/Variation/Explore?r=1:115700259-115701259;v=rs7521023;vdb=variation;vf=502256217 (18 February 2019).
Review
For citations:
Muslimova E.F., Rebrova T.Yu., Archakov E.A., Kondratieva D.S., Lugacheva Yu.G., Batalov R.E., Afanasiev S.A. Association of polymorphic variants rs6684209 and rs7521023 of the calsequestrin gene (CASQ2) with contractile myocardial function in patients with coronary artery disease. Russian Journal of Cardiology. 2019;(10):16-21. (In Russ.) https://doi.org/10.15829/1560-4071-2019-10-16-21